Find out about CVRM news!
At AstraZeneca, each and every one of us firmly believes that science is at the heart of everything we do. Our Mission is to protect millions of patients to stop the progression of Cardiovascular, Kidney and Metabolic Diseases.
Find a wide variety of content with information and
scientific support from the brands of the Cardiovascular franchise
Below, you will find the different areas covered by our CVRM line, in addition to campaigns and events organized by AstraZeneca Central America and the Caribbean.
CARDIOVASCULAR
HEALTH
Access scientific information, specialized and updated on HEART FAILURE
Click here
KIDNEY HEALTH
Access scientific information,specialized and updated on Chronic Kidney Disease
Click here
Featured Content
In this section you will find scientific and updated information about Cardiovascular diseases, drug information or
different activities for HCP´s organized by AstraZeneca for Central America and the Caribbean.
Próximos eventos
Eventos exclusivos para profesionales de la Salud . Haga click para más información
Dislipidemia en el paciente con diabetes,
¿cómo tratarla?
Ponente: Dr. Óscar Emilio Pinzón
Día: 16 de Marzo de 2021
Horario: 19:00hs. GT
Inscríbase aquí
Dislipidemia en el paciente con diabetes,
¿cómo tratarla?
Ponente: Dr. Óscar Emilio Pinzón
Día: 16 de Marzo de 2021
Horario: 19:00hs. GT
Inscríbase aquí
Dislipidemia en el paciente con diabetes,
¿cómo tratarla?
Ponente: Dr. Óscar Emilio Pinzón
Día: 16 de Marzo de 2021
Horario: 19:00hs. GT
Inscríbase aquí
Dislipidemia en el paciente con diabetes,
¿cómo tratarla?
Ponente: Dr. Óscar Emilio Pinzón
Día: 16 de Marzo de 2021
Horario: 19:00hs. GT
Inscríbase aquí
CVRM: Cardiovascular, renal and metabolic.
Exclusive material for health professionals.Produced by AstraZeneca CAMCAR Costa Rica S.A. Roble Corporate Center, 5th floor, Escazú, San José Costa Rica, phone: (506) 2201-3400, P.O. Box: 993-1260 Escazú.www.camcar.astrazeneca.com for AstraZeneca CAMCAR S.A. To report an adverse event please send an email to:https://www.contactazmedical.astrazeneca.com CC-11170 / November 2025